This
page discusses regimens of hrt, progesterone intolerance, cyclic therapy,
continuous combined therapy, premarin, aygestin and prometrium ...
The defining difference between HRT programs for women with and without
a uterus is the need to give progesterone (progestin) when the uterus
is present. For this reason HRT programs for women who have had a hysterectomy
are less complex and avoid the symptoms of progesterone intolerance
experienced by many women.
PROGESTERONE
INTOLERANCE
Approximately 30-40%
of women who take progesterone experience unpleasant PMS-like symptoms
which can range from mild to severe such as moodiness, irritably, breast
tenderness and muscle aches. Individuals who had significant premenstrual
symptoms while they were premenopausal are more likely to be affected.
Progestins produce moodiness and irritability by effecting specific
sites in the brain. Changing the type of progesterone, the dose, the
route of administration and the length of treatment can lessen this
effect. Forms of natural progesterone given by either the oral or vaginal
route may be less of a problem than synthetic progestins. But some patients
are so sensitive to the effects of progesterone they continue to have
significant problems and just feel miserable. It is one of the most
challenging aspects of caring for the postmenopausal woman. A few physicians
are vigorous in their suggestion that natural progesterone cream as
sole therapy is a miracle treatment for the postmenopausal woman, however
a careful and responsible analysis of accepted medical literature and
investigations does not support this view.
WOMEN WITH
A UTERUS
HRT programs for
women who have not had a hysterectomy fall into two categories, Cyclic,
where progesterone is given for part of the month and continuous combined
therapy (CCT), where it is given daily.
Cyclic Therapy
Cyclic therapy usually
consists of the daily administration of estrogen usually in the form
of an oral estrogen tablet or a transdermal estrogen patch replaced
once or twice weekly but worn continually plus progesterone in tablet
form taken 10-12 days a month. Estrogen stimulates and thickens the
endometrium, (the lining of the uterus) and then progesterone, which
has antiestrogenic effects blocks the estrogen stimulation. Progesterone
both shrinks the uterine lining and prevents the development of abnormal
changes.
Alternatively, the
route of administration of the estrogen can be sublingual, transdermal
gel or subcutaneous implantation. The route of administration of the
progesterone can include sublingual tablets and vaginal suppositories.
If this works the way it's supposed to, 2-5 days after finishing the
progesterone the patient experiences "scheduled withdrawal bleeding"
which usually lasts from 3-5 days. And this "cycle" is repeated
monthly. If the bleeding occurs at any other time during the month it
is called "unscheduled bleeding" and signals the need to determine
if any overgrowth or abnormal change of the uterine lining is present.
Continuous
Combined Therapy
Continuous combined
therapy usually consists of a daily estrogen tablet or a transdermal
estrogen patch worn as above plus a smaller dose of progesterone taken
daily. The purported benefit of this regimen is that in the majority
of cases daily progesterone even in small doses keeps the uterine lining
thin and no bleeding occurs. Menstrual bleeding is a very unattractive
prospect for many postmenopausal women.
Some common oral
estrogen and progesterone combinations. For years the most frequently
prescribed combination consisted of conjugated equine estrogen tablets
(brand name Premarin) and medroxyprogesterone acetate (MPA) tablets
(brand name Provera). The congugated equine estrogen (CEE) or Premarin
in earlier years was usually given in dose of 1.25 mg daily the 1-25th
days of the month and the Provera was given the 16-25th days of the
month. Nothing was given from the 17th to the end of the month at which
time the cycle was repeated. Many women experienced symptoms such as
hot flashes or sweats during the time they were off the estrogen and
in more recent years the (CEE) is most commonly every day instead of
the 1-25th. The dose of CEE in most HRT regimens is usually lower and
is most frequently .625 mg. I have found that most of the time if a
patients symptoms are not alleviated by this dose that higher doses
are no more effective and another product or route of administration
might be more effective. The MPA is usually given in a dosage of 10mg
for 10-12 days a month. Some physicians give the MPA in a lower dose
such as 5mg or every 2nd or third month to decrease the incidence of
PMS like effects but this is a trade off you must be aware of as the
protection of the uterine is lessened.
In more recent years
additional formulations of estrogen and progesterone were developed
and are often substituted in this regimen. Micronized estradiol brand
name Estrace is from a plant source and has the hypothetical advantage
of actually being estradiol the bioactive form of estrogen although
it is altered during intestinal absorption as any other oral preparation
would be. Some other brands of oral estrogen preparations include Ogen
and Estratab.
Norethindrone acetate,
brand name Aygestin and oral micronized progesterone brand name Prometrium
are both commonly used forms of oral progesterone replacement. Aygestin
is more potent in its ability to shrink the lining of the uterus and
is useful as an alternative to MPA when heavy or "unscheduled bleeding"
is a problem. It is available as a 5 mg tablet and can be given in doses
ranging from 1/4 of a tablet to 2 tablets 10-12 days a month according
to each individual's needs. Prometrium seems to cause less PMS-like
effects in women who are sensitive to progestins. It is distributed
in 100 mg tablets and is usually given in a dose of 2 tablets at bedtime
for 10-12 days a month.